Hbvtech
2 known investors
HBVtech develops a gene therapy platform intended to treat chronic infections with a single injection. Its lead program targets chronic hepatitis B (cHBV) infections, aiming for a lasting cure through a single administration.
BiotechHealthtech
Investors · 2
Frequently asked questions
- What does Hbvtech do?
- HBVtech develops a gene therapy platform intended to treat chronic infections with a single injection. Its lead program targets chronic hepatitis B (cHBV) infections, aiming for a lasting cure through a single administration.
- Who are Hbvtech's investors?
- Hbvtech's investors include Maryland TEDCO, TEDCO.